Germinal center B-cell-like diffuse Large B-cell Lymphoma (GCB) DLBCL

Abstract

Review on Germinal center B-cell-like diffuse Large B-cell Lymphoma (GCB) DLBCL, with data on clinics, and genes.

A Patent Foramen Ovale Grants Cardiac Output Over an Obstructive Primary Cardiac Lymphoma

“…However, chemotherapy has been associated with a better prognosis, 6 with reports of median overall survival of 63 months 2 and an overall cure rate of 70% to 80% in the germinal center subtype of diffuse large B-cell lymphomas. 7 Little is known about predictors of better outcome, but BCL2 positivity and high median proliferative index, presented by this patient, are associated with a high response rate to chemotherapy. However, the presence of extracardiac disease was associated with worse overall survival.…”